Redcare Pharmacy NV reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 560.22 million compared to EUR 372.05 million a year ago. Net loss was EUR 7.81 million compared to EUR 10.22 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
118 EUR | +2.21% | +3.41% | -10.18% |
Jun. 10 | REDCARE PHARMACY : UBS gives a Sell rating | ZD |
Jun. 06 | REDCARE PHARMACY : Berenberg gives a Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.18% | 2.52B | |
-38.99% | 13.75B | |
-36.57% | 10.33B | |
-10.38% | 7.94B | |
+4.30% | 5.86B | |
-14.62% | 5.69B | |
-3.21% | 4.65B | |
+69.95% | 4.46B | |
-8.55% | 3.79B | |
-22.93% | 3.05B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Redcare Pharmacy NV Reports Earnings Results for the First Quarter Ended March 31, 2024